TRANSPERS Center Research
The objective of TRANSPERS Center research is to use an integrated, interdisciplinary, and innovative approach to obtain evidence about how genomic information is being translated into clinical practice and health policy.
Center research explores central questions related to the application of personalized medicine in clinical care, including:
- Who has access to the newest technologies? Is equal access provided to minorities and those who are less educated or who donít have insurance?
- How do patients and providers make decisions about using personalized tests or drugs?
- What information do insurers need to make the most appropriate decisions about whether to cover personalized medicine technologies?
- How can we better design policies to encourage the most effective use of technologies?
We develop interconnected projects and working groups around:
- Health care utilization
- Costs and cost-effectiveness
- Evidence development and evaluation
- Diverse populations
- Decision making (patient, provider, payer, government), and
We ground analyses in real-world examples, including:
- Existing and emerging technologies in breast cancer (e.g. HER2, CYP2D6, gene expression)
- Genetic testing for risk of an inherited colorectal cancer, Lynch Syndrome, and
- Reimbursement and coverage decisions for personalized medicine
- Benefits and risks of whole genome sequencing
And, we work with leading experts and organizations in the emerging field of personalized medicine, facilitating:
- Opportunities for training and development (e.g. post doctoral fellows), and
- Ongoing development of new collaborations